Arcutis Biotherapeutics, Inc. (ARQT)
NMS – Real vaqt narxi. Valyuta: USD
27.00
+0.31 (1.16%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
26.64
-0.36 (-1.33%)
Bozordan keyin: Jun 26, 2026, 5:37 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
27.00
+0.31 (1.16%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
26.64
-0.36 (-1.33%)
Bozordan keyin: Jun 26, 2026, 5:37 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $114.7M naqd pul zahiralaridan ($35.1M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $438.1M jami joriy majburiyatlardan $163.2M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.6) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-2.1x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Kompaniya ijobiy erkin pul oqimi $2.2M generatsiya qiladi, moliyaviy salomatligini qo'llab-quvvatlaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 2.68 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 2.46 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.60 | 0.30 | 7.0 | |
| Qarz/Aktivlar nisbati | 0.25 | 1.04 | 7.0 | |
| Foiz to‘lov qoplami | -2.08 | -16.91 | 1.0 | |
| O‘rtacha ball | 7.0 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 4M | 60M | 197M | 376M | 416M |
| Yalpi foyda | 2M | 53M | 177M | 339M | 378M |
| Operatsion daromad | -302M | -241M | -128M | -12M | 3M |
| Sof foyda | -311M | -262M | -140M | -16M | -2M |
| EBITDA | -300M | -239M | -126M | -7M | 6M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 44.21 | 132.21 | 10 |
| Keyingi chorak | 30.04 | 38.58 | 10 |
| Joriy yil | 32.18 | 253.13 | 10 |
| Keyingi yil | 29.92 | 436.89 | 10 |
| O‘rtacha ball | 10 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | -18.6 | -164.92 | -169.22 | -91.44 | 1.0 |
| Yil/Yil | 60.07 | 54.93 | 55 | 107.23 | 10 |
| 3 yil o‘rtacha | 612.72 | 50.29 | 63.77 | 51.03 | 10 |
| 5 yil o‘rtacha | 767.23 | 9.58 | 29.19 | 10.25 | 8.3 |
| O‘rtacha ball | 7.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |